Abstract:The prevalence of food allergies (FAs) has increased considerably in recent decades, with the only available treatment being the avoidance of the specific food items causing the allergy. FAs may have a major impact on quality of life, and it is of great interest to explore new strategies to prevent and treat FAs. Some studies show an altered gut microbiota profile in individuals with FAs, and the modulation of gut microbiota is therefore proposed as a potential strategy for prevention and treatment. This systematic review aimed to investigate: (1) the gut microbiota profile in individuals with FAs compared to healthy individuals and (2) the effect of fecal microbiota transplantation (FMT) on gut microbiota profiles and/or allergy symptoms. A literature search was conducted in PubMed (Medline) on 5 April 2022. Of the 236 publications identified, 12 studies were included based on inclusion and exclusion criteria. Eleven of these studies reported results on the gut microbiota in children with FAs compared to healthy controls (HCs). The majority of studies (six studies) observed no difference in alpha diversity when comparing children with FAs to HCs; however, a difference in beta diversity was observed in five studies. At the phylum level, we observed a high abundance of Firmicutes (six studies) and Proteobacteria (five studies), whereas a low abundance of Bacteroidetes (5 studies) was observed in children with FAs compared to HCs. Of the 12 included studies, four explored the effect of FMT on gut microbiota and/or allergy symptoms. Three studies reported that transferring gut microbiota from children without FAs to germ-free mice, protected the mice against allergic reactions, whereas one study did not report findings on the allergic symptoms. The results on gut microbiota after FMT varied and were too divergent to draw any conclusions. Overall, our results suggest that there are differences in the gut microbiota profile in individuals with FAs compared to individuals without FAs. FMT seems to be a promising strategy to prevent allergic symptoms but needs to be further explored in animal and human models. As the findings in this review are based on a small number of studies (12 studies), further studies are warranted before any clear conclusions can be drawn regarding gut microbiota profiles and the effect of FMT on individuals with FAs.

Microbiota therapy acts via a regulatory T cell MyD88/RORγt pathway to suppress food allergy

Altered fecal microbiota composition associated with food allergy in infants.

Fecal microbiota transplantation alleviates food allergy in neonatal mice via the PD-1/PD-L1 pathway and change of the microbiota composition

The microbial origins of food allergy

Clostridia protect from food allergy by promoting intestinal barrier integrity and modulating retinoic acid metabolism

Micro RNA-155 Plays a Critical Role in the Initiation of Food Allergen-Related Inflammation in the Intestine.

A microbiota signature associated with experimental food allergy promotes allergic sensitization and anaphylaxis

A synbiotic of Anaerostipes caccae and lactulose prevents and treats food allergy in mice

A single species bacterial therapy reduces type 2 immune responses in the gut to prevent food allergy

The Gut Microbiome-Immune Axis As a Target for Nutrition-Mediated Modulation of Food Allergy

Exploring the Molecular Mechanisms Underlying the Protective Effects of Microbial SCFAs on Intestinal Tolerance and Food Allergy

Maternal microbiome regulation prevents early allergic airway diseases in mouse offspring

Pathogenic mechanisms in the evolution of food allergy

Short‐chain Fatty Acids As a Target for Prevention Against Food Allergy by Regulatory T Cells

Gut Microbiota Promotes Immune Tolerance by Regulating RORγt+ Treg Cells in Food Allergy

Microbial intestinal dysbiosis drives long-term allergic susceptibility by sculpting an ILC2-B1 cell-innate IgE axis

Pathophysiological Mechanisms of Gut Dysbiosis and Food Allergy and an Investigation of Probiotics as an Intervention for Atopic Disease

TFR cell-mediated regulation of IgA and gut microbiota in food allergy

[Microbiota in food allergy: prebiotics, probiotics and synbiotics]

Multi-omics reveals Bifidobacterium longum CECT7894 alleviate food allergy by regulating the Sphingolipid metabolism pathway

Gut Microbiota and Fecal Microbiota Transplantation in Patients with Food Allergies: A Systematic Review